CTOs on the Move

MolecularMD

www.molecularmd.com

 
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Holly Hill Manor

Holly Hill Manor is a Towson, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EHE Health

EHE is America`s leading prevention company. We work with major clients from diverse fields to help their employees reach optimal health through comprehensive exams and year-round mentoring and resources. Our holistic, personalized approach improves longevity, productivity, and performance. For more than 100 years, EHE has led the way in preventive health care. We continue to grow and innovate, providing individuals with what they need to feel their best every day.

Clear Stone Central Lab

Clear Stone Central Lab is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heart Force Medical

Heart Force Medical Inc. (HFM), a private company, has invented and has patents pending for the digital Ballistocardiograph (dBG(TM)). The dBG 300, which is already approved in Canada and the United States, captures the movement of the heart during each cardiac cycle (heart beat). This movement (acceleration and force) is sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM's proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.

Network Health

Since 1997, Network Health has been committed of improving the health and well-being of its members and their diverse communities. Today the company provides high-quality, comprehensive health care coverage to more than 160,000 residents who qualify for Mass Health and Commonwealth Care in more than 300 cities and towns across Massachusetts.